ClassID:

116182

C12Y301/01013 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Carboxylic ester hydrolases (3.1.1) Sterol esterase (3.1.1.13)

Recent Application in this class:
#1
20250327111
2025-10-23

REAGENT COMPOSITION AND KIT

#2
20250276035
2025-09-04

ANTIBACTERIAL POLYPEPTIDES

#3
20250025538
2025-01-23

METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS

#4
20240124859
2024-04-18

TARGET PROTEIN PRODUCTION METHOD

#5
20240115735
2024-04-11

MATERIALS AND METHODS FOR THE TREATMENT OF LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)

#6
20240067942
2024-02-29

LYSOSOMAL ACID LIPASE VARIANTS AND USES THEREOF

#7
20230243857
2023-08-03

KIT AND METHOD

#8
20230085357
2023-03-16

INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF

#9
20230027119
2023-01-26

METHODS FOR THE PRODUCTION OF FERULIC ACID

#10
20220362350
2022-11-17

Methods for treating lysosomal acid lipase deficiency in patients

#11
20220251172
2022-08-11

RECOMBINANTLY ENGINEERED, LIPASE/ESTERASE-DEFICIENT MAMMALIAN CELL LINES

#12
20220228152
2022-07-21

OLIGONUCLEOTIDE THERAPY FOR WOLMAN DISEASE AND CHOLESTERYL ESTER STORAGE DISEASE

#13
20220177812
2022-06-09

Detergent composition

#14
20220170059
2022-06-02

MICROORGANISM HAVING ENHANCED L-THREONINE PRODUCING ABILITY AND METHOD FOR PRODUCING THREONINE USING THE SAME

#15
20220162581
2022-05-26

Solution Stable Enzyme Composition

#16
20210371866
2021-12-02

Methods and compositions for treatment of cholesteryl ester storage disease

#17
20210171922
2021-06-10

Lysosomal storage disease enzymes

#18
20210071156
2021-03-11

Lipase Variants and Compositions Thereof

#19
20210071155
2021-03-11

Lipase Variants and Compositions Thereof

#20
20200208082
2020-07-02

Method for using lipase enzymes for cleaning

#21
20200205423
2020-07-02

Lipase enzymes

#22
20200063113
2020-02-27

Lysosomal storage disease enzymes

#23
20190282671
2019-09-19

Methods for treating lysosomal acid lipase deficiency in patients

#24
20190250155
2019-08-15

BEAD-BASED ENZYMATIC ASSAY

#25
20190151420
2019-05-23

Lysosomal acid lipase deficiency compositions and methods

#26
20190125842
2019-05-02

LYSOSOMAL ACID LIPASE THERAPY FOR NAFLD AND RELATED DISEASES

#27
20190093054
2019-03-28

Detergent compositions comprising lipases

#28
20190076508
2019-03-14

Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment

#29
20170314000
2017-11-02

Lysosomal storage disease enzymes

#30
20170296631
2017-10-19

LIPID HYDROLYSIS THERAPY FOR ATHEROSCLEROSIS AND RELATED DISEASES

#31
20170266264
2017-09-21

TRUNCATED LYSOSOMAL ACID LIPASE

#32
20170151313
2017-06-01

Lipid hydrolysis therapy for atherosclerosis and related diseases

#33
20160367645
2016-12-22

LYSOSOMAL ACID LIPASE THERAPY FOR NAFLD AND RELATED DISEASES

#34
20160051638
2016-02-25

Methods for treating lysosomal acid lipase deficiency in patients

#35
20150283215
2015-10-08

METHOD TO INCREASE THE GROWTH VELOCITY OF HUMAN INFANTS

#36
20150191714
2015-07-09

FORMULATIONS OF RECOMBINANT HUMAN BILE SALT-STIMULATED LIPASE

#37
20150098933
2015-04-09

TRUNCATED LYSOSOMAL ACID LIPASE

#38
20150030582
2015-01-29

Lysosomal Storage Disease Enzyme

#39
20140348752
2014-11-27

METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS

#40
20120100126
2012-04-26

Method to increase the growth velocity of human infants

#41
20120064055
2012-03-15

Methods for treating lysosomal acid lipase deficiency in patients

#42
20100239558
2010-09-23

Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases

#43
20090297496
2009-12-03

Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases

#44
20070264249
2007-11-15

Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases